张哲

个人信息Personal Information

教授 博士生导师 硕士生导师

任职 : Aging,Cancer,Cancer Genetics,Oncology Letters,General Physiology and Biophysics ,Experimental and Therapeutic Medicine,Food & Function, Psychosomatic Medicine Research(Section Editor), Current Pharmaceutical Biotechnology, 中国生物工程杂志,解剖科学进展

性别:男

毕业院校:清华大学

学历:研究生(博士)毕业

学位:博士生

所在单位:基础医学院

入职时间:2021-01

学科:遗传学
发育生物学
生物化学与分子生物学

办公地点:山东大学趵突泉校区电镜楼209

联系方式:

扫描关注

论文成果

当前位置: 中文主页 >> 科学研究 >> 论文成果

FLVCR2: structure, substrate transport, and emerging roles in human disease

点击次数:

论文名称:FLVCR2: structure, substrate transport, and emerging roles in human disease

发表刊物:Life Sciences

关键字:FLVCR2; Solute carrier; Choline transport; Blood-brain barrier; Fowler syndrome; Ferroptosis

摘要:The feline leukemia virus subgroup C receptor 2 (FLVCR2), a key member of the solute carrier (SLC) major facilitator superfamily (MFS), is a highly conserved transmembrane protein with diverse and critical functions in mammalian biology. Although once proposed as an extracellular heme importer, recent functional and structural studies strongly support FLVCR2 as a primary choline transporter, notably at the blood-brain barrier (BBB). Cryo-electron microscopy (cryo-EM) has resolved the outward-facing (OFS) and inward-facing (IFS) conformations, providing a molecular understanding of its classic MFS fold and the proposed proton-dependent rocker-switch mechanism for choline transport. This structural clarity definitively resolves the primary substrate debate. Mutations in FLVCR2 are the cause of Fowler syndrome (PVHH), resulting from severely impaired central nervous system (CNS) vascular development. Beyond this, FLVCR2 maintains systemic heme homeostasis, with its deficiency linked to exacerbation of hemolytic-induced lung injury via ferroptosis. Finally, its role in choline transport makes its upregulation in malignancies, such as acute myeloid leukemia (AML), significant, positioning FLVCR2 as a potential prognostic tumor biomarker and therapeutic target. Further research is necessary to fully exploit its clinical potential.

第一作者:Liyuan Huang,Mengxiao Wu,Meixi Gong

通讯作者:张哲

全部作者:Lingfan Zhu,Chen Zhang,Yujie Ding

卷号:390

DOI码:10.1016/j.lfs.2026.124269

是否译文:

发表时间:2026-04

收录刊物:SCI

发布期刊链接:https://www.sciencedirect.com/science/article/pii/S0024320526000779?dgcid=author

发布时间:2026-06-12